Change - Announcement of Cessation::RESIGNATION OF CHIEF OPERATING OFFICER

Issuer & Securities

Issuer/ Manager
OUE LIPPO HEALTHCARE LIMITED
Securities
OUE LIPPO HEALTHCARE LTD - SG2F86994413 - 5WA
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
18-Nov-2019 22:43:51
Status
New
Announcement Sub Title
RESIGNATION OF CHIEF OPERATING OFFICER
Announcement Reference
SG191118OTHRR6EC
Submitted By (Co./ Ind. Name)
Mr. Yet Kum Meng
Designation
Chief Executive Officer and Executive Director
Description (Please provide a detailed description of the event in the box below)
This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"), in accordance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship (Mailing address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: sponsorship@ppcf.com.sg).

Additional Details

Name Of Person
Dr. Tan Tiong Chin Louis
Age
37
Is effective date of cessation known?
Yes
If yes, please provide the date
04/02/2020
Detailed Reason (s) for cessation
Pursue other opportunities.

After having interviewed Dr. Tan Tiong Chin Louis and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that, save as disclosed in this announcement, there are no material reasons for the cessation of Dr. Tan Tiong Chin Louis as the Chief Operating Officer.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
04/01/2018
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
4
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Operating Officer
Role and responsibilities
Dr. Tan Tiong Chin Louis manages and oversees the overall operations of the Group.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil.
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Dr. Tan Tiong Chin Louis holds 9,874 ordinary shares in OUE Lippo Healthcare Limited.

Past (for the last 5 years)
Sixtyone Pte. Ltd.
Present
OUELH Japan Management K.K.
Jiangsu Chang San Jiao Biomedical Co., Ltd.
Pun Hlaing International Hospital Limited
Yoma Siloam Hospital Pun Hlaing Limited